Journal
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION
Volume 2, Issue 4, Pages 210-226Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jash.2008.02.001
Keywords
Natriuretic peptide receptors; gene targeting; cardiovascular events; intracellular signaling
Categories
Funding
- National Institutes of Health [HL57531, HL62147]
Ask authors/readers for more resources
Thus far, three related natriuretic peptides (NPs) and three distinct receptors have been identified, which have advanced our knowledge towards understanding the control of high blood pressure, hypertension, and cardiovascular disorders to a great extent. Biochemical and molecular studies have been advanced to examine receptor function and signaling mechanisms and the role of second messenger cyclic guanosine monophosphate in pathophysiology of hypertension, renal hemodynamics, and cardiovascular functions. The development of gene-knockout and gene-duplication mouse models along with transgenic mice have provided a framework for understanding the importance of the antagonistic actions of NP receptors in cardiovascular events at the molecular level. Now, NPs are considered as circulating markers of congestive heart failure, however, their therapeutic potential for the treatment of cardiovascular diseases such as hypertension, renal insufficiency, cardiac hypertrophy, congestive heart failure, and stroke has just begun to unfold. Indeed, alternative avenues of investigations in this important area need to be undertaken, as we are at the initial stage of the molecular therapeutic and pharmacogenomic implications. J Am Soc Hypertens 2008;2(4): 210-226. (C) 2008 American Society of Hypertension. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available